THIRUVANANTHAPURAM (TOI): Malabar Cancer Centre has signed a memorandum of understanding with Kottakkal P S Varier Ayurveda College to explore the possibilities of integrating ayurveda in cancer care.
“Ayurveda is known for medicines for pain management and palliative care. We want to explore the possibility of utilising these in cancer care. Since these drugs are not scientifically proven, we have decided to begin joint research and clinical trials as per the guidelines of Indian Council of Medical Research (ICMR) and Ayush,” said Dr Satheesan Balasubramanian, director, Malabar Cancer Centre.
“The move could be revolutionary as no major institutions have made such an attempt. What we are aiming at is integrating medicines for cancer care. There are many side effects for radiation and chemotherapy and ayurveda reportedly has several drugs for such side effects. We want to study them scientifically and make use of them,” he said.
Balakrishna Kurup, chief executive officer of the college, said ayurveda could do a lot in developing immunity. “This could be a major booster in palliative care and this is the area we are planning to concentrate. If we can provide solace to a desperate patient, then there is nothing better than that.”
Balasubramaniam said the MoU was elaborate and it stresses combined research and clinical trials.
“The clinical trials will be conducted after getting clearances from the ethical committees of ICMR and Ayush.”
He said a sedentary lifestyle and food habits were major causes of cancers. Experts have pointed out that cancer could be prevented if the lifestyle and food habits prescribed in ayurveda treatment are followed. It’s also found that cancer could be controlled if detected in the initial stages and all these could be explored in the joint research, he said.
A research team from Kottakkal has innovated a package of ayurveda medicines for cancer-related research and is working on classical ayurvedic modalities to improve the quality of life of the terminally-ill. Kottakkal Arya Vaidya Sala has already formulated a therapeutic procedure.